Lower C-reactive protein level seen with self-monitoring program

03/8/2013 | PhysiciansBriefing.com

Data on 483 patients with poorly controlled, insulin-naive type 2 diabetes showed those in a structured intervention for self-monitoring of their blood glucose levels attained greater reductions in their level of high-sensitivity C-reactive protein at three, six and 12 months compared with those in the control group. The results appear in Diabetes Care.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC